STOCK TITAN

Anterix (ATEX) CEO receives new RSU and stock option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Anterix Inc. reported that President and CEO Scott A. Lang received new equity awards. He was granted 18,210 shares of Common Stock as restricted stock units and now directly holds 26,470 common shares after this award.

Lang also received stock options for 72,839 shares of Common Stock at an exercise price of $60.90 per share, expiring on May 20, 2036. Both the RSUs and the options vest over three years, with one-third vesting on May 20, 2027 and the remaining portions vesting in equal quarterly installments through May 20, 2029.

Positive

  • None.

Negative

  • None.

Insights

CEO received routine three-year RSU and option grants as equity compensation.

President and CEO Scott A. Lang was granted 18,210 restricted stock units tied to Anterix Common Stock and 72,839 stock options with a $60.90 exercise price, expiring on May 20, 2036. These awards appear to be compensation-related, not open-market trades.

The RSUs and options vest over three years, with one-third vesting on May 20, 2027 and the rest in equal quarterly installments through May 20, 2029. This structure encourages medium-term retention and alignment with shareholders without signaling any buy or sell decision in the market.

Insider Lang Scott A.
Role President and CEO
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 72,839 $0.00 --
Grant/Award Common Stock 18,210 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 72,839 shares (Direct, null); Common Stock — 26,470 shares (Direct, null)
Footnotes (1)
  1. Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029. The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
RSU grant 18,210 shares Restricted stock units granted to CEO on May 20, 2026
Shares held after grant 26,470 shares Common Stock directly owned by CEO following RSU award
Stock options granted 72,839 options Options on Common Stock granted on May 20, 2026
Option exercise price $60.90 per share Exercise price for 72,839 stock options
Option expiration May 20, 2036 Expiration date of CEO’s new stock options
Initial vesting date May 20, 2027 One-third of RSUs and options vest on this date
Final vesting date May 20, 2029 Quarterly vesting continues through this date
restricted stock units ("RSUs") financial
"Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 60.9000"
exercise price financial
"conversion_or_exercise_price: "60.9000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Common Stock financial
"Each RSU represents a contingent right to receive one share of Issuer's Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lang Scott A.

(Last)(First)(Middle)
3 GARRET MOUNTAIN PLAZA
SUITE 401

(Street)
WOODLAND PARK NEW JERSEY 07424

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A18,210(1)A$026,470D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$60.905/20/2026A72,839 (2)05/20/2036Common Stock72,839$072,839D
Explanation of Responses:
1. Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
2. The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.
Remarks:
/s/ Gena L. Ashe05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Anterix (ATEX) CEO Scott A. Lang report?

Anterix CEO Scott A. Lang reported receiving equity compensation grants, not market trades. He was awarded 18,210 restricted stock units and 72,839 stock options, both tied to Anterix Common Stock, with multi-year vesting schedules designed to align his interests with long-term shareholder value.

How many Anterix (ATEX) shares does the CEO hold after this Form 4?

After the reported grant, Scott A. Lang directly holds 26,470 shares of Anterix Common Stock. In addition, he holds stock options covering 72,839 underlying shares, which are separate from his direct share ownership and become exercisable over a three-year vesting period.

What are the terms of Scott A. Lang’s new Anterix (ATEX) stock options?

The new stock options give Scott A. Lang the right to buy 72,839 Anterix shares at an exercise price of $60.90 per share. These options expire on May 20, 2036 and vest over three years, with one-third vesting in 2027 and the rest quarterly through 2029.

How do the new restricted stock units for Anterix (ATEX) CEO vest?

The 18,210 restricted stock units granted to Scott A. Lang vest over three years. One-third of the RSUs vest on May 20, 2027, and the remaining two-thirds vest in equal quarterly installments on specified dates through May 20, 2029, subject to continued service.

Does the Anterix (ATEX) Form 4 show the CEO buying or selling shares on the market?

The Form 4 reflects equity compensation awards, not open-market buying or selling. The transactions are coded as grants or awards, meaning the CEO received restricted stock units and stock options from the company rather than trading existing Anterix shares in the public market.

What is the significance of the three-year vesting schedule in Anterix (ATEX) CEO’s awards?

The three-year vesting schedule means Scott A. Lang earns his RSUs and options gradually over time. One-third vests in 2027 and the rest quarterly through 2029, encouraging leadership retention and linking compensation to Anterix’s performance over multiple years instead of a single date.